Organization | Dermatologic Cooperative Oncology Group

Dermatologic Cooperative Oncology Group Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Kiel Germany (1990)

Organization Overview

First Clinical Trial

2001

NCT00226473

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2008

Timeline

NOW

Now

Active Ingredients

Drugs in Phase 4 Trials (3)

cisplatin (platinol) (1 trial)

dacarbazine (dtic-dome) (1 trial)

vindesine (Eldisine) (1 trial)

Drugs in Phase 3 Trials (2)

interferon alpha-2a (roferon-a) (1 trial)

interferon alpha-2b (Intron-A) (3 trials)

Drugs in Phase 2 Trials (2)

imatinib (gleevec) (1 trial)

sorafenib (nexavar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Dermatofibrosarcoma (Phase 2)

Melanoma (Phase 4)

Neoplasm Metastasis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 5
# of Trial APIs: 7